Metabolic dysfunction-associated steatohepatitis (MASH): Difference between revisions
ClaireLewis (talk | contribs) |
|||
| Line 11: | Line 11: | ||
*[[Cirrhosis]] | *[[Cirrhosis]] | ||
*[[Hepatitis]] | *[[Hepatitis]] | ||
*[[ | *[[Viral hepatitis]] | ||
*[[Autoimmune hepatitis]] | |||
*[[Wilson's disease]] | |||
*[[Hemochromatosis]] | |||
*[[Hepatocellular carcinoma]] | *[[Hepatocellular carcinoma]] | ||
*[[CHF]] (right heart failure]] | *[[CHF]] (right heart failure]] | ||
Revision as of 07:08, 18 August 2022
Background
- Fatty liver disease due to causes other than excessive alcohol
- Associated with insulin resistance and metabolic syndrome
Clinical Features
- Often asymptomatic or with mild RUQ discomfort
- Signs of portal hypertension (e.g. ascites) if advanced fibrosis
- Hepatomegaly
Differential Diagnosis
- Cirrhosis
- Hepatitis
- Viral hepatitis
- Autoimmune hepatitis
- Wilson's disease
- Hemochromatosis
- Hepatocellular carcinoma
- CHF (right heart failure]]
Evaluation
Management
- Treat complications of portal hypertension, if present
Disposition
- Discharge unless complications